Jiangsu Apon Medical Technology Co Ltd Class A (300753) — Cash Flow Reinvestment Rate
Jiangsu Apon Medical Technology Co Ltd Class A (300753) has a Cash Flow Reinvestment Rate of 0.12x as of December 2024, reinvesting CN¥5.78 Million (capex CN¥5.48 Million plus investments CN¥-300.00K) from operating cash flow of CN¥49.02 Million. Check 300753 cash flow quality score to evaluate the quality of earnings relative to operating cash generation.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Jiangsu Apon Medical Technology Co Ltd Class A Cash Flow Reinvestment Rate (2014–2024)
Historical reinvestment intensity for Jiangsu Apon Medical Technology Co Ltd Class A across 9 annual periods. Explore Jiangsu Apon Medical Technology Co Ltd C debt service capacity to assess how comfortably operating cash covers total debt obligations.
Annual Cash Flow Reinvestment Rate for Jiangsu Apon Medical Technology Co Ltd Class A (2014–2024)
Year-by-year capital reinvestment analysis for Jiangsu Apon Medical Technology Co Ltd Class A. For live market cap and broader valuation context, see Jiangsu Apon Medical Technology Co Ltd C (300753) market capitalisation.
| Year | Reinvestment Rate | Total Reinvested (CNY) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.98x | CN¥15.33 Million | CN¥15.68 Million | CN¥10.23 Million | ▼ -71.2% |
| 2021 | 3.40x | CN¥62.10 Million | CN¥18.29 Million | CN¥39.60 Million | ▲ +221.5% |
| 2020 | 1.06x | CN¥88.04 Million | CN¥83.34 Million | CN¥35.64 Million | ▲ +20.7% |
| 2019 | 0.88x | CN¥67.93 Million | CN¥77.59 Million | CN¥58.33 Million | ▼ -3.9% |
| 2018 | 0.91x | CN¥71.19 Million | CN¥78.13 Million | CN¥61.59 Million | ▲ +141.9% |
| 2017 | 0.38x | CN¥25.27 Million | CN¥67.08 Million | CN¥15.66 Million | ▼ -6.6% |
| 2016 | 0.40x | CN¥24.58 Million | CN¥60.97 Million | CN¥4.33 Million | ▲ +395.4% |
| 2015 | 0.08x | CN¥3.10 Million | CN¥38.08 Million | CN¥3.10 Million | ▲ +2.4% |
| 2014 | 0.08x | CN¥2.66 Million | CN¥33.49 Million | CN¥2.66 Million | — |